Search Results 131-140 of 17100 for Pyogenic
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
About this study. This phase II trial studies how well sapanisertib works in treating patients with pancreatic neuroendocrine tumor that has spread to other ...
The aim of this study is to describe management and outcomes (subjective function, return to play, complications) of competitive wrestlers presenting with Morel ...
Predictors of Treatment Failure in Patients With Pyogenic Brain Abscess. World Neurosurg X. 2022 Oct; 16:100134 Epub 2022 Aug 08. View PubMed; Flurin L, Wolf ...
Fuel groundbreaking medical research! ... Your donation powers the future of medicine and helps save lives. Give Today.
The study will evaluate the efficacy and safety of gevokizumab in treating active ulcers of pyoderma gangrenosum (PG). Participation eligibility. Participant ...
The objective of this study is to compare the central neural circuitry with fMRI (7T) in 30 asymptomatic healthy controls, 30 constipated patients without ...
About this study. The purpose of this study is to analyze and report orbital decompression outcomes in patients with a thyroid eye disease diagnosis.
Ibrutinib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Rituximab is a monoclonal antibody that may interfere with ...
She received her MD, MS and PhD in China and was a post-doctoral researcher in immunogenetics and transplant Immunology at UCLA Immunogenetics Center, UCLA and ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.